Astrantus »

Quest Diagnostics Incorporated shares owned by Astrantus

Quarter-by-quarter ownership of Quest Diagnostics Incorporated (DGX) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Quest Diagnostics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Quest Diagnostics Incorporated held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quest Diagnostics Incorporated by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $383k 2.8k 136.79

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Quest Diagnostics Incorporated

Vanguard Group
BlackRock
State Street Corporation
T. Rowe Price Associates
Victory Capital Management
Geode Capital Management
Davis Selected Advisers
Wellington Management Company
American Century Companies
Grantham, Mayo, Van Otterloo & Co
Dimensional Fund Advisors
Invesco
Jpmorgan Chase & Co
Wells Fargo & Company
Fiduciary Management

View all funds holding Quest Diagnostics Incorporated